Dr. Brian Roche, General Manager at Charles River’s Kansas site, has more than 20 years’ experience in preclinical drug development through multiple roles with a focus on research from early pharmacology through GLP safety pharmacology studies. In his previous role as the Executive Director of Global Safety Pharmacology, he provided scientific expertise and leadership on behalf of the Global Safety Pharmacology portfolio, including strategy development and best practice alignment across sites.
Dr. Roche received his doctorate in cardiovascular physiology from Ohio State University under the guidance of Dr. Robert Hamlin and he furthered his education at Ohio State as a postdoctoral research fellow. He is an active member of the international scientific community and served as the president of the Safety Pharmacology Society in 2021. Dr. Roche, who is dual boarded as a Toxicologist (DABT) and Safety Pharmacologist (DSP), published 24 peer-reviewed scientific papers and a chapter book.
Unlock Faster, Smarter Toxicology Decisions
Learn how real-time toxicology data and digital pathology drive accelerated decision-making and reduce costly delays.
Watch the Webinar